Bavachin enhances paclitaxel sensitivity in ovarian cancer cells through modulation of mitochondrial function and ER stress
Bavachin, a bioactive phytoestrogen from Psoralea corylifolia, has shown promising therapeutic potential in various cancers, but its effects on ovarian cancer remain unexplored. In this study, we investigate the anti-cancer mechanisms of bavachin in ES2 and OV90 ovarian cancer cells and its potentia...
Saved in:
| Main Authors: | Sang-Jin Lee, Kee K. Kim, Jin-Young Lee |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2025-12-01
|
| Series: | Animal Cells and Systems |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/19768354.2025.2520852 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Bavachin ameliorates cisplatin-induced nephrotoxicity by enhancing mitochondrial β-oxidation and lipid metabolism through MFN2
by: Shilu Luo, et al.
Published: (2025-06-01) -
Micellar paclitaxel in the treatment of patients with tumors of the female reproductive system
by: A. G. Kedrova, et al.
Published: (2019-11-01) -
Sulindac exhibits anti-proliferative and anti-invasive effects and enhances the sensitivity to paclitaxel in ovarian cancer
by: Shuning Chen, et al.
Published: (2025-04-01) -
Combination of Cannabidiol with Cisplatin or Paclitaxel Analysis Using the Chou–Talalay Method and Chemo-Sensitization Evaluation in Platinum-Resistant Ovarian Cancer Cells
by: Jana Ismail, et al.
Published: (2025-02-01) -
The Impact of Carboplatin Dosing Design Using Adjusted Serum Creatinine on Carboplatin Plus Paclitaxel Therapy for Ovarian Cancer
by: Shu Kato, et al.
Published: (2025-04-01)